All details for Patel Chem Specialities IPO: Dates, price, financials, objectives, KPIs, registrar, and business overview.
Bar Chart upar, Line Chart niche — financials section me!
Patel Chem Specialities IPO: At a Glance
IPO Timeline
| IPO Activity | Date |
|---|---|
| IPO Open Date | July 25, 2025 |
| IPO Close Date | July 29, 2025 |
| Basis of Allotment (Tentative) | July 30, 2025 |
| Refunds Initiation (Tentative) | July 31, 2025 |
| Credit of Shares to Demat (Tentative) | July 31, 2025 |
| IPO Listing Date (Tentative) | August 1, 2025 |
IPO Price & Lot Size
| Issue Price | ₹84 per share |
|---|---|
| Market Lot | 1,600 Shares |
| Retail Min | 2 lots (3,200 shares) – ₹2,68,800 |
| Retail Max | 2 lots (3,200 shares) – ₹2,68,800 |
| S-HNI Min | 3 lots (4,800 shares) – ₹4,03,200 |
| S-HNI Max | 7 lots (11,200 shares) – ₹9,40,800 |
| B-HNI Min | 8 lots (12,800 shares) – ₹10,75,200 |
Company Financials (₹ Crore)
Bar Chart: Revenue, PAT & Net Worth
Line Chart: Revenue, PAT & Net Worth
| Period Ended | Assets | Revenue | Profit After Tax | EBITDA | Net Worth | Reserves & Surplus | Total Borrowing |
|---|---|---|---|---|---|---|---|
| 31 Mar 2025 | 65.31 | 105.55 | 10.57 | 15.80 | 35.40 | 17.53 | 14.85 |
| 31 Mar 2024 | 46.97 | 82.72 | 7.66 | 12.02 | 19.52 | 18.52 | 15.46 |
| 31 Mar 2023 | 37.08 | 69.75 | 2.89 | 5.83 | 11.87 | 10.87 | 11.79 |
Key Performance Indicators (KPI)
| KPI | Values |
|---|---|
| ROE | 29.85% |
| ROCE | 36.26% |
| Debt/Equity | 0.42 |
| RoNW | 24.32% |
| PAT Margin | 10.01% |
| EBITDA Margin | 14.97% |
| Price to Book Value | 4.11 |
| EPS (Pre IPO) | 5.91 |
| EPS (Post IPO) | 4.25 |
| P/E (Pre IPO) | 14.21 |
| P/E (Post IPO) | 19.77 |
Objects of the Issue
| S.No. | Objects of the Issue | Expected Amount (₹ Million) |
|---|---|---|
| 1 | Funding capital expenditure requirement of the Company | 431.48 |
| 2 | General corporate purposes | – |
About Patel Chem Specialities Ltd.
Incorporated: 2008
Business: Manufacturer and exporter of pharmaceutical excipients and specialty chemicals for pharma, food, cosmetics, and industrial applications.
Products:
- Rheollose® (Sodium Carboxymethyl Cellulose): Thickening/stabilizing agent
- Disolwell® (Croscarmellose Sodium): Super disintegrant for pharma
- Swellcal® (Calcium Carboxymethyl Cellulose): Pharma super disintegrant
- AmyloTab™ (Pregelatinized Starch): Tablet disintegration
Export: East Asia, Europe, Middle East, North America, Southeast Asia.
Employees: 136 (as of March 31, 2025)
Promoters: Bhupesh Patel, Anshu Patel, Vini Patel
- Leading specialty chemical & excipient manufacturer
- Strong global presence and certifications
- Modern R&D, QC, and bulk capacity
Contact Details
Plot No. 272/4-5, Phase II, G.I.D.C Industrial Estate,
Vatva Road, Ahmedabad, Gujarat, 382445
Phone: +91 9712999854
Email: cs@patelchem.com
Website: https://patelchem.com/
Frequently Asked Questions (FAQ)
The issue price for Patel Chem Specialities IPO is ₹84 per share.
The IPO is scheduled to open for subscription on July 25, 2025, and close on July 29, 2025.
The minimum investment for retail investors is ₹2,68,800 (3,200 shares or 2 lots at ₹84 per share). The minimum lot size is 1,600 shares. For small HNI (sNII), the minimum investment is ₹4,03,200 (4,800 shares or 3 lots). For big HNI (bNII), the minimum investment is ₹10,75,200 (12,800 shares or 8 lots).
You can apply for the IPO through:
- Your bank's net banking platform (ASBA facility)
- Brokerage accounts, using UPI or offline forms
- Registered investment platforms
- Designated branches of syndicate banks
Retail investors can bid at the fixed price. Detailed instructions are available in the Red Herring Prospectus (RHP).
Patel Chem Specialities Ltd. is a manufacturer and exporter of pharmaceutical excipients and specialty chemicals for pharmaceutical, food, cosmetics, and industrial applications. Its revenue sources include:
- Sale of pharmaceutical excipients like Rheollose® (Sodium Carboxymethyl Cellulose), Disolwell® (Croscarmellose Sodium), Swellcal® (Calcium Carboxymethyl Cellulose), and AmyloTab™ (Pregelatinized Starch)
- Export of specialty chemicals to East Asia, Europe, Middle East, North America, and Southeast Asia
- Custom manufacturing for pharma, food, and cosmetic industries
The company operates two manufacturing facilities in Vatva (Ahmedabad) and Talod (Himmatnagar) with a combined annual capacity of 7,200 MT, supported by US-DMF and GMP certifications.
Key risks to consider include:
- Market risk: Dependence on demand from pharmaceutical and export markets
- Operational risk: Reliance on raw material availability and compliance with stringent quality standards
- Debt risk: Borrowings of ₹14.85 Cr with a debt-to-equity ratio of 0.42 as of FY25
- Competition: Intense competition from global and domestic specialty chemical manufacturers
- Regulatory risk: Compliance with international certifications (e.g., US-DMF, GMP) and environmental regulations
Investors should review the risk factors in the RHP before investing.
The net proceeds from the fresh issue (₹58.80 Cr) will be used for:
- Funding capital expenditure requirements: ₹43.15 Cr
- General corporate purposes: Remaining amount
Patel Chem Specialities has shown consistent growth:
- Revenue growth: ₹69.75 Cr (FY23) to ₹82.72 Cr (FY24) to ₹105.55 Cr (FY25), a 28% increase from FY24 to FY25
- Profit after tax: ₹2.89 Cr (FY23) to ₹7.66 Cr (FY24) to ₹10.57 Cr (FY25), a 38% increase from FY24 to FY25
- Net worth: ₹11.87 Cr (FY23) to ₹19.52 Cr (FY24) to ₹35.40 Cr (FY25)
- Production capacity: 7,200 MT annually across two facilities in Gujarat, with US-DMF and GMP certifications
- Employee strength: 136 employees as of March 31, 2025
The company’s strong R&D, global export presence, and certified manufacturing drive its growth.
As of March 31, 2025:
- Total borrowings: ₹14.85 Cr
- Debt-to-equity ratio: 0.42
- Revenue: ₹105.55 Cr, supporting debt servicing capacity
The company’s low debt-to-equity ratio indicates a stable financial position.
The book running lead manager for the Patel Chem Specialities IPO is not specified in the provided details. The registrar is MUFG Intime India Private Limited (Link Intime). The market maker is Globalworth Securities Limited.
Note: The information provided here is based on the RHP and available data as of July 26, 2025. For the most updated and accurate details, including subscription status and grey market premium, please refer to the Red Herring Prospectus (RHP) or consult with your financial advisor.
